107 related articles for article (PubMed ID: 15073544)
1. Anorexigenic C75 alters c-Fos in mouse hypothalamic and hindbrain subnuclei.
Miller I; Ronnett GV; Moran TH; Aja S
Neuroreport; 2004 Apr; 15(5):925-9. PubMed ID: 15073544
[TBL] [Abstract][Full Text] [Related]
2. Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem.
Gao S; Lane MD
Proc Natl Acad Sci U S A; 2003 May; 100(10):5628-33. PubMed ID: 12724522
[TBL] [Abstract][Full Text] [Related]
3. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
[TBL] [Abstract][Full Text] [Related]
4. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.
Shimokawa T; Kumar MV; Lane MD
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):66-71. PubMed ID: 11756683
[TBL] [Abstract][Full Text] [Related]
5. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
Hu Z; Cha SH; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
[TBL] [Abstract][Full Text] [Related]
7. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
Hu Z; Cha SH; van Haasteren G; Wang J; Lane MD
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3972-7. PubMed ID: 15728730
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice.
Kumar MV; Shimokawa T; Nagy TR; Lane MD
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1921-5. PubMed ID: 11854492
[TBL] [Abstract][Full Text] [Related]
9. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Takahashi KA; Smart JL; Liu H; Cone RD
Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
[TBL] [Abstract][Full Text] [Related]
10. Importance of melanocortin signaling in refeeding-induced neuronal activation and satiety.
Singru PS; Sánchez E; Fekete C; Lechan RM
Endocrinology; 2007 Feb; 148(2):638-46. PubMed ID: 17068131
[TBL] [Abstract][Full Text] [Related]
11. Effects of CCK-8 on independent ingestion and central c-Fos-like immunoreactivity in rats on postnatal days 10 and 11.
Blumberg S; Schroeder M; Haba D; Malkesman O; Torregrossa AM; Weller A; Smith GP
Peptides; 2006 Nov; 27(11):2820-8. PubMed ID: 16860903
[TBL] [Abstract][Full Text] [Related]
12. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
[TBL] [Abstract][Full Text] [Related]
13. Induction of Fos-like immunoreactivity in the rat hypothalamus by an endogenous feeding suppressant (2-buten-4-olide).
Hisano S; Uemura N; Fukui Y; Miki M; Zhang R
Neurosci Lett; 1994 Nov; 182(1):80-2. PubMed ID: 7891895
[TBL] [Abstract][Full Text] [Related]
14. Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice.
Pirník Z; Kolesárová M; Železná B; Maletínská L
Neurochem Int; 2018 Jun; 116():77-84. PubMed ID: 29601847
[TBL] [Abstract][Full Text] [Related]
15. The connections between C75 and obesity drug-target pathways.
Kuhajda FP; Landree LE; Ronnett GV
Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
[TBL] [Abstract][Full Text] [Related]
16. The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons.
Shu IW; Lindenberg DL; Mizuno TM; Roberts JL; Mobbs CV
Brain Res; 2003 Sep; 985(1):1-12. PubMed ID: 12957363
[TBL] [Abstract][Full Text] [Related]
17. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
18. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
19. Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.
Rohrbach KW; Han S; Gan J; O'Tanyi EJ; Zhang H; Chi CL; Taub R; Largent BL; Cheng D
Eur J Pharmacol; 2005 Mar; 511(1):31-41. PubMed ID: 15777777
[TBL] [Abstract][Full Text] [Related]
20. Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: co-staining with vasopressin, oxytocin, and tyrosine hydroxylase.
Pirnik Z; Kiss A
Brain Res Bull; 2005 May; 65(5):423-31. PubMed ID: 15833597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
